| scholarly article | Q13442814 |
| P50 | author | Fabio Tascedda | Q41701739 |
| Nicoletta Brunello | Q41701746 | ||
| Silvia Alboni | Q43285239 | ||
| Cristina Benatti | Q56947165 | ||
| P2093 | author name string | Joan M C Blom | |
| Julien Mendlewicz | |||
| Giacomo Capone | |||
| Philippe Kriwin | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluoxetine | Q422244 |
| P304 | page(s) | 219-25 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | International Clinical Psychopharmacology | Q15751307 |
| P1476 | title | Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression | |
| P478 | volume | 21 |
| Q48042512 | ASPREE-D: Aspirin for the prevention of depression in the elderly. |
| Q40156599 | Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. |
| Q48311920 | Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson's disease. |
| Q41452561 | Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats |
| Q36439429 | Antiinflammatory treatment ameliorates HPA stress axis dysfunction in a mouse model of stress sensitivity |
| Q35678040 | Aspirin and multiple sclerosis |
| Q92862577 | COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders |
| Q35531978 | Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial |
| Q48843502 | Constant darkness induces IL-6-dependent depression-like behavior through the NF-κB signaling pathway. |
| Q34078917 | Cytokine targets in the brain: impact on neurotransmitters and neurocircuits |
| Q37183514 | Depression: A repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? |
| Q46851797 | Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats |
| Q47936163 | Genome-wide analysis of LPS-induced inflammatory response in the rat ventral hippocampus: Modulatory activity of the antidepressant agomelatine |
| Q33721031 | Immunological aspects of the treatment of depression and schizophrenia |
| Q37310533 | Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. |
| Q36023793 | Inflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes |
| Q28288750 | Inflammatory biomarkers and depression |
| Q35774501 | Is depression an inflammatory disorder? |
| Q60954979 | Metoprolol, N-Acetylcysteine, and Escitalopram Prevents Chronic Unpredictable Mild Stress-Induced Depression by Inhibition of Endoplasmic Reticulum Stress |
| Q37399776 | Mind and body: how the health of the body impacts on neuropsychiatry. |
| Q30573306 | Multinomial modeling and an evaluation of common data-mining algorithms for identifying signals of disproportionate reporting in pharmacovigilance databases |
| Q90264439 | Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders |
| Q28220405 | Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression |
| Q36067322 | Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression? |
| Q50061128 | The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial |
| Q37624657 | The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment. |
| Q38004705 | The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications |
| Q47785792 | Therapeutic strategies for treatment of inflammation-related depression. |
| Q39295049 | Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress |
Search more.